Which antibiotic regimen is appropriate for treating cellulitis?

Antibiotic Selection for Cellulitis

For nonpurulent cellulitis (typical cellulitis without drainage or abscess), treat with a beta-lactam antibiotic targeting streptococci—specifically cephalexin 500 mg four times daily or penicillin—for 5 days. 1, 2, 3, 4

Clinical Classification: Purulent vs. Nonpurulent

The first critical step is determining whether the cellulitis is purulent or nonpurulent, as this fundamentally changes your antibiotic choice:

Nonpurulent Cellulitis (Most Common)

• Presentation: Erythema, warmth, swelling, tenderness WITHOUT purulent drainage, exudate, or drainable abscess
• Causative organisms: β-hemolytic streptococci (primarily)
• First-line treatment: Beta-lactam antibiotics 1, 2, 1
  • Cephalexin 500 mg PO four times daily
  • Dicloxacillin 500 mg PO four times daily
  • Penicillin or amoxicillin (standard doses)
• Duration: 5 days if clinical improvement occurs 3, 4, 5

Critical point: MRSA coverage is NOT routinely needed for typical nonpurulent cellulitis. Multiple studies confirm that beta-lactams alone (cefazolin, oxacillin) achieve 96% success rates even in settings with high MRSA prevalence for other infections 5. The IDSA guidelines explicitly state that empirical MRSA coverage for nonpurulent cellulitis is "likely unnecessary" 1, 2, 1.

Purulent Cellulitis

• Presentation: Cellulitis WITH purulent drainage or exudate (but no drainable abscess requiring I&D)
• Causative organisms: Community-acquired MRSA (CA-MRSA) is primary concern
• First-line treatment: MRSA-active antibiotics 1, 2, 1
  • TMP-SMX 1-2 double-strength tablets twice daily
  • Doxycycline 100 mg twice daily
  • Clindamycin 300-450 mg three times daily
• Duration: 5-10 days based on clinical response 1, 2

When to Add MRSA Coverage to Nonpurulent Cellulitis

Add MRSA-active therapy to nonpurulent cellulitis ONLY in these specific scenarios 1, 2, 1:

1. Failure to respond to beta-lactam therapy after 48-72 hours
2. Systemic toxicity (fever >38°C, tachycardia >90, tachypnea >24, WBC >12,000 or <4,000)
3. Penetrating trauma, especially injection drug use
4. Known MRSA colonization or prior MRSA infection
5. Immunocompromised state

For dual coverage (streptococci + MRSA) when needed 1, 2:

• Clindamycin alone (covers both), OR
• TMP-SMX or doxycycline PLUS a beta-lactam (e.g., amoxicillin or cephalexin)

Hospitalized Patients with Complicated SSTI

For severe cellulitis requiring hospitalization 1, 2:

• IV vancomycin (first-line)
• Linezolid 600 mg IV/PO twice daily
• Daptomycin 4 mg/kg IV once daily
• Telavancin 10 mg/kg IV once daily
• Clindamycin 600 mg IV three times daily (if local resistance <10%)
• Duration: 7-14 days, individualized to clinical response

For hospitalized patients with nonpurulent cellulitis, you can still start with cefazolin IV and switch to MRSA-active therapy only if no clinical response 1.

Common Pitfalls to Avoid

1. Over-treating typical cellulitis with MRSA coverage: The evidence is clear that streptococci cause the vast majority of nonpurulent cellulitis. A recent double-blind study showed TMP-SMX plus cephalexin was no better than cephalexin alone for pure cellulitis 5.

2. Treating too long: The 2021 American College of Physicians guidelines and multiple RCTs confirm 5-6 days is sufficient for uncomplicated cellulitis if clinical improvement occurs 4, 5. The traditional 10-14 day courses are unnecessary.

3. Ordering unnecessary cultures: Blood cultures and tissue aspirates are NOT needed for typical cellulitis 5. Reserve cultures for: severe systemic illness, immunocompromised patients, failure of initial therapy, or unusual exposures (water, animal bites).

4. Missing cellulitis mimics: Before prescribing antibiotics, exclude venous stasis dermatitis, contact dermatitis, deep venous thrombosis, and other non-infectious causes 6, 7. Bilateral cellulitis is rare—consider alternative diagnoses 6.

Pediatric Considerations

• Avoid tetracyclines (doxycycline, minocycline) in children <8 years old 1
• For hospitalized children: vancomycin is first-line 1, 2
• Alternative: clindamycin 10-13 mg/kg/dose IV every 6-8 hours if local resistance <10% 1
• Linezolid: 10 mg/kg/dose every 8 hours for children <12 years; 600 mg twice daily for ≥12 years 1

Special Populations

Pregnant women: Avoid TMP-SMX in third trimester (category C/D) and infants <2 months 1

Elderly patients on ACE inhibitors/ARBs with renal insufficiency: Use TMP-SMX with caution due to hyperkalemia risk 1